A 28-year-old woman with borderline lepromatous leprosy develops erythema nodosum leprosum (Type 2 lepra reaction). Which is the most common site of involvement in this patient?

Explanation

## Type 2 Lepra Reaction (ENL): Sites of Involvement **Key Point:** Skin and subcutaneous tissues are the most common sites of involvement in erythema nodosum leprosum (Type 2 lepra reaction), occurring in nearly 100% of ENL cases. ### Clinical Manifestations of ENL by Site | Site | Frequency | Clinical Features | |------|-----------|-------------------| | **Skin & subcutaneous** | ~100% | Painful nodules, erythema, ulceration | | **Eyes** | 5–10% | Iritis, episcleritis, keratitis | | **Testes** | 5–10% | Orchitis, pain, infertility risk | | **Joints** | 10–15% | Arthralgia, arthritis (hands, knees) | | **Nerves** | 10–20% | Neuritis, nerve damage | | **Liver** | 5–10% | Hepatomegaly, elevated transaminases | | **Kidneys** | 5–10% | Glomerulonephritis, proteinuria | | **Lymph nodes** | 10–15% | Lymphadenopathy | **High-Yield:** While ENL is a systemic immune complex-mediated reaction, skin involvement is **universal** and the presenting feature in virtually all cases. Systemic manifestations (fever, arthralgia, lymphadenopathy) occur in 50–80% of patients, but skin lesions are always present. **Clinical Pearl:** The hallmark of ENL is the appearance of **painful, tender subcutaneous nodules** that are distinct from the original leprosy lesions. These nodules are erythematous, may suppurate, and are exquisitely tender to palpation. **Mnemonic:** **SKIN-FIRST rule for ENL** - **S**kin: always involved (100%) - **K**idneys, Liver: less common (5–10%) - **I**nflammation: systemic (fever, arthralgia) - **N**erves: neuritis (10–20%) - **F**irst manifestation: cutaneous nodules - **I**ris/eyes: less common (5–10%) - **R**are: testes (5–10%) - **S**evere: can progress to systemic complications ### Why Skin is Most Commonly Involved 1. **Immune complex deposition:** Circulating immune complexes deposit preferentially in skin microvasculature 2. **High antigen concentration:** Skin contains residual mycobacterial antigens from the primary disease 3. **Vascular accessibility:** Skin has rich microvasculature where immune complexes lodge 4. **Universal presentation:** ENL always manifests with cutaneous nodules; systemic features are variable ### Distinction from Other Sites While systemic involvement (eyes, testes, joints, kidneys) can occur and is clinically significant, these are **secondary manifestations** in a minority of ENL cases. Skin involvement is the **primary and universal** feature that defines the reaction.